Vimarsana
Biggest News Aggregation in the World

Page 14 - Joint Undertaking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joint Undertaking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joint Undertaking Today - Breaking & Trending Today

EHang to demonstrate eVTOL medical air mobility via SAFIR-Med project - Vimarsana News

EHang to demonstrate eVTOL medical air mobility via SAFIR-Med project

Photo Credit: EHang Holdings Ltd. EHang Holdings Ltd. (Guangzhou, China) announced on Feb. 5 its participation as the only passenger eVTOL partner in the SAFIR-Med (Safe and Flexible Integration of Advanced U-Space Services for Medical Air Mobility) project, a research and innovation project to promote the use of unmanned aviation in healthcare systems across the European Union (EU). The project, which aims to ensure that healthcare is of high quality and accessible to all citizens of the EU, has selected 17 partners from eight countries and is supported by eight cross-industry advisory b...

European consortium forms to standardize fuel cell modules for heavy-duty applications: StaSHH - Vimarsana News

European consortium forms to standardize fuel cell modules for heavy-duty applications: StaSHH

European consortium forms to standardize fuel cell modules for heavy-duty applications: StaSHH A European consortium consisting of 25 organizations in the hydrogen sector has formed to define, develop and test the first European standard for fuel-cell modules for heavy-duty applications. The consortium—“StaSHH” (Standard-Sized Heavy-duty Hydrogen)—comprises 11 fuel cell module suppliers, 9 original equipment manufacturers and 5 research, test, engineering and/or knowledge institutes. StaSHH will standardize physical dimensions, flow and digital interfaces, test protocols and safety re...

Europe launches smart air mobility trials - Vimarsana News

Europe launches smart air mobility trials

By Ben Spencer Sesar’s air mobility trials will take place in the Netherlands, Spain and the UK (© Resul Muslu | Dreamstime.com) A European Commission (EC) project to see if drones can help ease road congestion has been unveiled. The Single European Sky ATM Research (Sesar) U-space demonstration project includes input from EHang is to conduct air mobility trials over the next two years.  Sesar – a programme that coordinates European Union R&D activities in air traffic management (ATM) – is managed by a partnership called SESAR Joint Undertaking whose members include Indra and Th...

T2EVOLVE: breakthrough alliance boosting Europe to the forefront of [...] - Vimarsana News

T2EVOLVE: breakthrough alliance boosting Europe to the forefront of [...]

03 febbraio 2021 12:02 Fonte: Adnkronos #salute-e-benessere THE HAGUE, Netherlands, Feb. 3, 2021 /PRNewswire/ -- T2EVOLVE is a new breakthrough alliance of academic and industry leaders in cancer immunotherapy under the European Union's Innovative Medicines Initiative (IMI). The key objective of T2EVOLVE is to accelerate development and increase awareness and access of cancer patients to immunotherapy with immune cells that harbor a genetically engineered T cell receptor (TCR) or synthetic chimeric antigen receptor (CAR). Simultaneously, T2EVOLVE aims to provide guidance on sustainable integr...

T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy - Vimarsana News

T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy

Share this article Share this article THE HAGUE, Netherlands, Feb. 3, 2021 /PRNewswire/ -- T2EVOLVE is a new breakthrough alliance of academic and industry leaders in cancer immunotherapy under the European Union's Innovative Medicines Initiative (IMI). The key objective of T2EVOLVE is to accelerate development and increase awareness and access of cancer patients to immunotherapy with immune cells that harbor a genetically engineered T cell receptor (TCR) or synthetic chimeric antigen receptor (CAR). Simultaneously, T2EVOLVE aims to provide guidance on sustainable integration of these treatme...